Produces and supplies industrial and medical gases, alongside a project engineering business. For FY26 the gases, related products and services segment generated 2,128.184 crore in revenue and 641.88 crore in EBIT, while the project engineering segment recorded 980.614 crore in revenue and 118.819 crore in EBIT. Per the segment disclosure, the gases stream made up 68.5% of period segment revenue and project engineering 31.5%. Operates 24 plants and 11 offices with 1,696 employees. The largest cost line is other operating expenses at 39.4% of revenue, with materials at 10.2%, depreciation at 9.3%, and employees at 2.2%. The company has invested in Zenataris Renewable Energy Private Limited, taking a 26.77% stake for captive procurement of renewable power for its operations, with Rs 69.90 crore paid in the final tranche of a Rs 105 crore commitment. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Gases, related products & services (69%), Project engineering (32%). Asset-heavy industrial gases and engineering business with depreciation at 9.3% of revenue
| ₹ crore · consolidated | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | — | — | 2,769 | 2,485 | 2,531 |
| EBITDA (ex other income) | — | — | 702 | 765 | 909 |
| margin % | — | — | 25.4 | 30.8 | 35.9 |
| Owners' profit | — | — | 434 | 455 | 549 |
| EPS, as reported (₹) | — | — | 50.90 | 53.33 | 64.37 |
| ROE % · ROCE % | — · — | — · — | 12.5 · 15.3 | 11.9 · 15.0 | 12.9 · 15.1 |
| Debt / equity (x) | — | — | 0.00 | 0.00 | 0.00 |
| Cash from operations | 385 | — | 437 | 584 | 786 |
| Capex | — | — | (572) | (1,331) | (766) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 634 | 606 | 592 | 571 | 644 | 701 | 614 | 694 |
| Profit before tax | 141 | 155 | 161 | 142 | 226 | 194 | 115 | 138 |
| Net profit | 106 | 116 | 118 | 107 | 171 | 193 | 77 | 105 |
| EPS (₹) | 12.48 | 13.64 | 13.88 | 12.57 | 20.05 | 22.67 | 9.08 | 12.26 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Gases, related products & services | 1,628 | 52.4 |
| Project engineering | 981 | 31.5 |
| Gases, related products and services | 500 | 16.1 |
| Total, before eliminations | 3,109 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| LINDE INDIA LIMITED ◆ | 53,303 | 97.6 | 12.49 | 57.4 | 12.9 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 10 Sept 2026 · Linde India 90th AGM minutes filed; Rs 12 dividend approved with Rs 8 special | board shareholder meetings | low | — | — |
| 13 Aug 2026 · Linde India 90th AGM clears Rs 12 dividend, FY26 results adoption | board shareholder meetings | medium | — | — |
| 11 Aug 2026 · Linde India Q1 FY27: revenue up 21.6% YoY to Rs 694 cr; Vikash Dokania named CFO | results | high | — | — |
| 11 Aug 2026 · Linde India Q1 FY27 results: revenue up 21.6% YoY, SEBI RPT matter flagged | results | high | — | — |
| 11 Aug 2026 · Linde India Q1 FY27: revenue up 22%, new CFO appointed | results | high | — | — |
| 10 Aug 2026 · Board meeting adjourned to 11 August for Q1 FY27 results | results | low | — | — |
| 3 Aug 2026 · Board Meeting on 10 Aug 2026 to approve Q1 FY27 results | results | low | — | — |
| 21 Jul 2026 · Linde India 90th AGM notice - 13 August 2026 via video conferencing | compliance | minimal | — | — |
| 21 Jul 2026 · Linde India 90th AGM on 13 Aug 2026; Annual Report on website | compliance | minimal | — | — |
| 20 Jul 2026 · Linde India files BRSR for FY26 with exchanges | compliance | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| 14.8 |
| — |
| 29.7 |
| ELLENBARRIE INDUS GASES L | 5,356 | 44.4 | 5.48 | — | 10.7 | 12.2 | — | 55.4 |
| STALLION IND FLUOROCHEM L | 2,613 | 39.1 | 3.84 | — | 6.4 | 8.7 | — | 20.8 |
| Hilltone Software and Gases Lt | 51 | 39.2 | 2.20 | — | 0.6 | (0.4) | — | (3.5) |
| NATIONAL OXYGEN LTD. | 28 | 2.3 | — | — | (30.1) | 10.1 | — | (18.9) |
| GAGAN GASES LTD. | 10 | 36.5 | 2.78 | — | 4.0 | 4.7 | — | 10.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 97.6 | 20.9 | 200 of 211 | 5% |
| P/B | 12.5 | 2.2 | 193 of 201 | 4% |
| ROCE | 14.8 | 8.2 | 62 of 225 | 73% |
| ROE | 12.9 | 7.2 | 56 of 212 | 74% |
| Debt / Equity | 0.0 | 0.2 | 12 of 212 | 80% |
| EBITDA margin | 29.7 | 14.0 | 22 of 201 | 90% |
| Revenue growth | 21.6 | 17.2 | 83 of 194 | 58% |
| Profit growth | (2.4) | 41.9 | 142 of 202 | 30% |
| Market cap | 53303 | 401 | 4 of 222 | 99% |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.